Increase of bioavailability of coenzyme Q10 and vitamin E

Journal of Medicinal Food

Volumn 10, Issue 4, 2007, Pages 731-734

  Wajda, Rudi ^a   Zirkel, Jürgen ^a   Schaffer, Tanja ^a  

^a Lipoid GmbH   (Germany)

Author keywords

Bioavailability; Coenzyme Q10; Drug delivery; Human study; NanoSolve; Phospholipids; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; GELATIN; NANOMATERIAL; NANOSOLVE; UBIDECARENONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALPHA-TOCOPHEROL; BIOLOGICAL AVAILABILITY; COENZYMES; CROSS-OVER STUDIES; FEMALE; HUMANS; INTESTINAL ABSORPTION; MALE; UBIQUINONE;

EID: 37549027986     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.254     Document Type: Article

References (7)

1. Weber C, Holmer A: Coenzyme Q10 in the diet - daily intake and relative bioavailability. Mol Aspects Med 1997;18:251-254.
2. Crane FL: Biochemical functions of coenzyme Q10. J Am Coll Nutr 2001;20:591-598.
3. Langsjoen PH, Langsjoen AM: Overview of the use of CoQ10 in cardiovascular disease. Biofactors 1999;9:273-284.
4. Wajda R: Emulsive water-soluble concentrates. Patent WO 2004/047791 A2. November 25, 2003.
5. Wajda R: NanoSolve - a new type of technique for the solubilization of lipophilic actives such as coenzyme Q10 or omega-3 fatty acids. Innov Food Technol 2004;8:32-33.
6. Back EI, Nohr D, Biesalski HK: Can changes in hydrophobicity increase the bioavailability of α-tocopherol? Eur J Nutr Online 2005;doi 10.1007/s00394-005-0556-9.
7. Mosca F, Fattorini D, Bompadre S, Littarru CP: Assay of coenzyme Q10 in plasma by a single dilution step. Anal Biochem 2002;305:49-54.